Literature DB >> 10504012

The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).

M J Müller1, P Marx-Dannigkeit, R Schlösser, H Wetzel, D Addington, O Benkert.   

Abstract

A German version of the Calgary Depression Rating Scale for Schizophrenia (CDSS-G) approved by the author of the original scale is presented comprising a semi-structured interview for 9 items to sensitively and specifically assess depression in schizophrenia and related disorders. The process of translation is outlined and the finally derived CDSS-G was investigated with respect to interrater reliability in three studies. To keep comparability with the CDSS source version a standard procedure was used. Two trained raters jointly assessed ten schizophrenic patients (study I). In a second study, videotapes with the CDSS-G were presented to clinically inexperienced raters (study II, N = 14/15) to test the agreement on the CDSS-G in this sample. Finally, in a third study clinically experienced researchers participated in a rater training (study III, N = 34). They carried out CDSS ratings on three patients with mild depressive symptoms. The dependence of interrater reliability on depression severity was investigated for all studied patients. Both intraclass correlation coefficients (ICC) and weighted kappa coefficients (kappa(w)) were calculated. The results revealed a high ICC = 0.97 in study I for the total CDSS-G score. Single item ICC values were all above 0.70. The results of study II revealed somewhat lower agreement on CDSS-G items and total scores in psychiatric novices with however acceptable values of kappa(w)>0.50 for the total scores. Study III yielded satisfactory results (0.66<kappa(w)<0.76) for clinically experienced psychiatrists in schizophrenic patients with mild depression. The results demonstrate adequate to excellent interrater reliability of the CDSS-G corroborating the results of the original version in different settings.

Entities:  

Mesh:

Year:  1999        PMID: 10504012     DOI: 10.1016/s0022-3956(99)00018-7

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  17 in total

1.  [Neuropsychology of psychoeducation in schizophrenia: results of the Munich COGPIP study].

Authors:  G Pitschel-Walz; A Gsottschneider; T Froböse; S Kraemer; J Bäuml; T Jahn
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

Review 2.  Motivational Deficits in Schizophrenia and the Representation of Expected Value.

Authors:  James A Waltz; James M Gold
Journal:  Curr Top Behav Neurosci       Date:  2016

3.  Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients With Schizophrenia.

Authors:  Joe J Simon; Sheila A Cordeiro; Marc-André Weber; Hans-Christoph Friederich; Robert C Wolf; Matthias Weisbrod; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2015-05-25       Impact factor: 9.306

4.  Agomelatine for Depression in Schizophrenia: A Case-Series.

Authors:  Jochen Mutschler; Nicolas Rüsch; Herdis Schönfelder; Uwe Herwig; Annette B Brühl; Martin Grosshans; Wulf Rössler; Heike Russmann
Journal:  Psychopharmacol Bull       Date:  2012-02-15

5.  Evaluation of an integrated care program for schizophrenia: concept and study design.

Authors:  L Kerkemeyer; S Mostardt; J Biermann; J Wasem; A Neumann; A Walendzik; R Jahn; C Bartels; P Falkai; W Brannath; V Breunig-Lyriti; B Mester; J Timm; T Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-07       Impact factor: 5.270

6.  Thematic analysis of the raters' experiences administering scales to assess depression and suicide in Arab schizophrenia patients.

Authors:  Iman Amro; Suhaila Ghuloum; Samer Hammoudeh; Yahya Hani; Arij Yehya; Hassen Al-Amin
Journal:  BMC Psychiatry       Date:  2022-10-21       Impact factor: 4.144

7.  Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.

Authors:  Jean Addington; Hely Shah; Lu Liu; Donald Addington
Journal:  Schizophr Res       Date:  2014-01-16       Impact factor: 4.939

8.  Why do bad things happen to me? Attributional style, depressed mood, and persecutory delusions in patients with schizophrenia.

Authors:  Stephanie Mehl; Martin W Landsberg; Anna-Christine Schmidt; Maurice Cabanis; Andreas Bechdolf; Jutta Herrlich; Stephanie Loos-Jankowiak; Tilo Kircher; Stephanie Kiszkenow; Stefan Klingberg; Mareike Kommescher; Steffen Moritz; Bernhard W Müller; Gudrun Sartory; Georg Wiedemann; Andreas Wittorf; Wolfgang Wölwer; Michael Wagner
Journal:  Schizophr Bull       Date:  2014-04-17       Impact factor: 9.306

9.  Depression in schizophrenia: methodological artifact or distinct feature of the illness?

Authors:  Eran Chemerinski; Christopher Bowie; Hannah Anderson; Philip D Harvey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

10.  Depression: An actionable outcome for those at clinical high-risk.

Authors:  Jean Addington; Megan S Farris; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; William S Stone; Matcheri Keshevan; Scott W Woods
Journal:  Schizophr Res       Date:  2020-10-29       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.